Ataciguat, a new drug being studied for aortic valve stenosis, shows promise in slowing disease progression and reducing the ...
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.
The phase II data are promising for patients who are managed with watchful waiting before being offered an intervention.
Calcific aortic valve disease (CAVD), and ensuing severe aortic stenosis (AS), is the foremost valvular disorder of aging, yet preventive therapies are lacking. A better understanding of the molecular ...
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage ...
Dr Boon, Department of Neurology of the St Anna Hospital, PO Box 90, 5660 AB, Geldrop, Netherlands. Aims To determine whether mitral annular calcification and aortic valve calcification, with or ...
3 天
Tribune Content Agency on MSNThe Medicine Cabinet: Ask the Harvard Experts: Why an aortic valve can narrow and impede ...Q: My doctor heard a new heart murmur and suspected I have a narrowed valve due to aortic stenosis. I feel fine. Why did this ...
5 天
News Medical on MSNNew drug ataciguat shows promise for managing aortic valve stenosisAortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果